1. Home
  2. MLYS vs IPAR Comparison

MLYS vs IPAR Comparison

Compare MLYS & IPAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mineralys Therapeutics Inc.

MLYS

Mineralys Therapeutics Inc.

HOLD

Current Price

$38.73

Market Cap

3.1B

Sector

Health Care

ML Signal

HOLD

Logo Inter Parfums Inc.

IPAR

Inter Parfums Inc.

HOLD

Current Price

$82.73

Market Cap

2.6B

ML Signal

HOLD

Company Overview

Basic Information
Metric
MLYS
IPAR
Founded
2019
1982
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Package Goods/Cosmetics
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
3.1B
2.6B
IPO Year
2023
1988

Fundamental Metrics

Financial Performance
Metric
MLYS
IPAR
Price
$38.73
$82.73
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
5
Target Price
$46.40
$128.20
AVG Volume (30 Days)
1.9M
286.0K
Earning Date
11-10-2025
11-05-2025
Dividend Yield
N/A
3.87%
EPS Growth
N/A
9.68
EPS
N/A
5.13
Revenue
N/A
$1,463,838,000.00
Revenue This Year
N/A
$3.42
Revenue Next Year
N/A
$1.53
P/E Ratio
N/A
$16.15
Revenue Growth
N/A
3.12
52 Week Low
$8.24
$77.21
52 Week High
$47.65
$148.15

Technical Indicators

Market Signals
Indicator
MLYS
IPAR
Relative Strength Index (RSI) 42.94 39.99
Support Level $41.50 $79.50
Resistance Level $44.13 $82.10
Average True Range (ATR) 2.37 2.76
MACD -0.63 0.54
Stochastic Oscillator 15.49 53.57

Price Performance

Historical Comparison
MLYS
IPAR

About MLYS Mineralys Therapeutics Inc.

Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administered, selective aldosterone synthase inhibitor, that is initially developed for the treatment of patients with uncontrolled hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking two or more lines of antihypertensive medication or resistant hypertension, typically including a diuretic.

About IPAR Inter Parfums Inc.

Interparfums Inc operates in the fragrance business and produces and distributes a wide array of prestige fragrance and fragrance-related products. It sells its product under the brand which includes Boucheron, Coach, Jimmy Choo, Karl Lagerfeld, Kate Spade, Lacoste, Lanvin, Moncler, Montblanc, Rochas and Van Cleef & Arpels. The company operates in two operating segments namely European based operations, SA, and United States based operations.. The group sells its products to department stores, perfumeries, specialty stores, and domestic and international wholesalers and distributors.

Share on Social Networks: